Arzeda - About the company
Arzeda is a series B company based in Seattle (United States), founded in 2008 by Alexandre Zanghellini, David Baker and Daniela Grabs-Rothlisberger. It operates as a Developer of enzyme design technology to bridge the gap by creating synthetic enzymes. Arzeda has raised $95.2M in funding from OS Fund and Conti Ventures. The company has 175 active competitors, including 31 funded and 28 that have exited. Its top competitors include companies like Nautilus Biotechnology, Somalogic and Biognosys.
Company Details
Developer of enzyme design technology to bridge the gap by creating synthetic enzymes. The proprietary technology combines targeted computational enzyme design and protein optimization with metabolic bioengineering to create entirely novel designer cell factories capable of industry-scale chemical production.
- Website
- www.arzeda.com/
- Social
- Registered Address
- Seattle, Washington
Key Metrics
Founded Year
2008
Location
Seattle, United States
Stage
Series B
Total Funding
$95.2M in 25 rounds
Latest Funding Round
Ranked
4th among 175 active competitors
Employee Count
78 as on Jun 30, 2026
Similar Companies
Legal entities associated with Arzeda
Arzeda is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Arzeda Corp CIN: 264339048 , United States, Active | Dec 31, 2007 | - | 66 (As on Dec 31, 2024) | - |
Sign up to download Arzeda's company profile
Arzeda's funding and investors
Arzeda has raised a total funding of $95.2M over 25 rounds. Arzeda has 24 institutional investors.
Here is the list of recent funding rounds of Arzeda:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Aug 28, 2025 | 7551519 | Series B | 3835227 | 7494636 | 1343378 | 8124300 |
May 28, 2025 | 2528067 | Grant (prize money) | 2371498 | 4398274 | 1102233 | |
Apr 08, 2025 | 5969588 | Grant (prize money) | 8928636 | 2071070 | 9903106 |
Access funding benchmarks and valuations. Sign up today!View details of Arzeda's funding rounds and investors
Arzeda's founders and board of directors
Founder? Claim ProfileThe founders of Arzeda are Alexandre Zanghellini, David Baker and Daniela Grabs-Rothlisberger. Alexandre Zanghellini is the CEO of Arzeda.
Here are the details of Arzeda's key team members:
- Alexandre Zanghellini: Co-Founder & CEO of Arzeda. They serve on the board of 1 company.Contact Info: 1 email address
- David Baker: Co-Founder of Arzeda.
- Daniela Grabs-Rothlisberger: Co-Founder of Arzeda.
Arzeda's Board of Directors
Arzeda's board has 14 active members. Larry Page, Doug Cameron, Alexandre Zanghellini, Sanjay Pal, Jeffrey Klunzinger, Brian Loeb, Jeff Klunzinger, Nanda Kumar R Puthucode, Daniela Grabs, Eric Althoff, William Baum, Yanniv Dorone, Bill Baum and Andrew Ban are independent board members.Here is the list of Arzeda's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Independent board member | - | Current | 2y 7m | |
hlikgds | Independent board member | - | Current | 1y 8m |
qtpvgme | Independent board member | - | Current | 4y 3m |
livifg{ | Independent board member | - | Current | 5y 6m |
llfitav | Independent board member | - | Current | 9y 8m |
zfowinb | Independent board member | - | Current | 9y 3m |
peaswms | Independent board member | - | Current | 2y 1m |
xprmcza | Independent board member | - | Current | 2y 1m |
zwhhadi | Independent board member | - | Current | 8y 1m |
tjdmpcl | Independent board member | - | Current | 7y 8m |
kziiiuz | Independent board member | - | Current | 5y 8m |
j{bcyoh | Independent board member | - | Current | 4y 2m |
ueotaxj | Independent board member | - | Current | 4y 3m |
kcajhop | Independent board member | - | Current | 9y 9m |
View details of Arzeda's Founder profiles and Board Members
Arzeda's employee count trend
Arzeda has 78 employees as of Jun 26. Here is Arzeda's employee count trend over the years:
Uncover Arzeda's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Arzeda's Competitors and alternates
Top competitors of Arzeda include Nautilus Biotechnology, Somalogic and Biognosys. Here is the list of Top 10 competitors of Arzeda, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Nautilus Biotechnology 2016, Seattle (United States), Public | Developer of proteomics platform for drug development | $453M | 65/100 | |
2nd | Somalogic 1999, Boulder (United States), Acquired | Developer of protein-based assays for life science research | $664M | 64/100 | |
3rd | Biognosys 2008, Schlieren (Switzerland), Acquired | Provider of proteomics service | $9.13M | 63/100 | |
4th | Arzeda 2008, Seattle (United States), Series B | Developer of enzyme design technology to bridge the gap by creating synthetic enzymes | $95.2M | 59/100 | |
5th | Amunix 2006, Mountain View (United States), Acquired | Developer of peptide-based therapeutics | $201M | 57/100 | |
6th | A-Alpha Bio 2017, Seattle (United States), Series A | Developer of cell-based tool for the measurements of protein interactions | $45.2M | 56/100 | |
7th | Dynamic Biosensors 2011, Planegg (Germany), Acquired | Provides solutions for label-free molecular interaction and biophysical analysis | $5.83M | 56/100 | |
8th | Mursla 2017, London (United Kingdom), Seed | Provider of diagnostic device for cancer detection | $547K | 55/100 | |
9th | ProteinSimple 2004, San Jose (United States), Acquired | Provider tools to help researchers with protein analysis | $94.3M | 54/100 | |
10th | Cevec Pharmaceuticals 2001, Cologne (Germany), Acquired | Provider of glyco-optimised human cell lines and gene therapy vectors using proprietary cell expression system | $28.4M | 52/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Arzeda's competitors? Click here to see the top ones
Arzeda's Investments and acquisitions
Arzeda has made no investments or acquisitions yet.
Reports related to Arzeda
Here is the latest report on Arzeda's sector:
News related to Arzeda
Filter this listMedia has covered Arzeda for a total of 5 events in the last 1 year, 2 of them have been about partnerships and 1 about company updates.
•
MANE Expands Partnership with Arzeda to Accelerate Global Commercialization of Vialeaf™ Reb MPR Newswire•Jul 16, 2026•Arzeda, MANE
•
Arzeda Adds COO and CTO to Drive Commercial Scale-Up of AI-Designed ProteinsTipRanks•Jun 23, 2026•Arzeda
•
Arzeda and KENT Specialty Milling Announce Strategic Product Development CollaborationPR Newswire•May 05, 2026•Arzeda
•
•
•
•
Arzeda: Protein Design Company Closes $38 Million In FundingPulse 2.0•Sep 23, 2024•Arzeda, Sofinnova Partners, , Sucden
•
Arzeda is using AI to design proteins for artificial sweeteners and moreTechCrunch+•Sep 17, 2024•Arzeda
•
Seattle startup Arzeda raises $38M to create proteins for food, pharma, and other industriesGeekWire•Sep 17, 2024•Arzeda, Sofinnova Partners, Fall Line Capital, Sucden and 5 others
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Arzeda
Explore our recently published companies
- Fabric - San Francisco based, 2022 founded, Funding Raised company
- Ambit Equity - Munich based, 2021 founded, Unfunded company
- A Malgam Technologies - Quebec City based, 2016 founded, Funding Raised company
- Billbo - Visakhapatnam based, Unfunded company
- Sooq Al Thahab - Manama based, 2022 founded, Funding Raised company
- Second Ocean - South Korea based, 2025 founded, Funding Raised company
